Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
MGI Tech and Predica Diagnostics Team Up for Precision RNA Sequencing in…
Empowering Precision Medicine Empowering Precision Medicine Predica Diagnostics, renowned for its expertise in cervical cancer screening through its proprietary ciRNAseq-based test, CervicaDx, brings unparalleled precision in identifying high-risk HPV oncogenes and other (pre)malignancy biomarkers. By integrating this advanced diagnostic capability with MGI's robust and affordable DNBSEQ technology, the partnership aims to significantly enhance the accuracy and accessibility of diagnostic...
PR Newswire
11/07/2024
Alvotech Announces Closing of Private Debt Financing
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing of its previously announced senior secured first lien term loan facility (the “Facility”). The closing has allowed Alvotech to refinance outstanding debt obligations, reduce the cost of capital and improve its overall debt maturity profile. Following the closing of the Facility, which included the settlement of existing...
Nasdaq GlobeNewswire
11/07/2024
Medit Appoints Han Ryu as CEO, Accelerating Digital Dentistry Innovation
Under Ryu's leadership, Medit aims to strengthen its presence and improve customer service in Europe. This involves establishing a new on-site office and warehouse in Europe to streamline communication and expedite product delivery. Additionally, Medit will introduce a '48-hour product exchange' service aimed at enriching customer experience. Medit is fostering strong partnerships and community initiatives within the dental market. This approach ensures ongoing alignment with market demands and…
PR Newswire
11/07/2024
Implantica announces new health-economics data publication showing RefluxStop™'s…
The study authors represent a partnership between the York Health Economics Consortium, UK and leading reflux centers of excellence in Switzerland, including Dr. med. Yves Borbély, Department of Visceral Surgery and Medicine, Inselspital Bern University Hospital, Switzerland, and Prof. Dr. med. Joerg Zehetner, Department of Visceral Surgery, Swiss1Chirurgie, Hirslanden Klinik Beau-Site Switzerland. The study authors represent a partnership between the York Health Economics Consortium, UK and...
PR Newswire
11/07/2024
Official Swiss delegation experiences new frontiers in art tech at HKBU
In his welcoming speech, Dr Clement Chen said the delegation's presence serves as a symbol of the strong ties between Hong Kong and Switzerland, and their shared dedication to excellence and innovation. In his welcoming speech, DrClement Chensaid the delegation's presence serves as a symbol of the strong ties between Hong Kong andSwitzerland, and their shared dedication to excellence and innovation. "HKBU is honoured to be chosen as one of the very few destinations during their tour...
PR Newswire
11/07/2024
NMD Pharma adds new capabilities with several senior recruits to support its…
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipelineAarhus, Denmark, 11 July 2024– NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with severe neuromuscular diseases, today announces that it has hired three senior recruits to its management team to support its growing business and pipeline. Peter Kasten will begin as Vice President Finance in August, Cecilia...
Nasdaq GlobeNewswire
11/07/2024
FURNITURE CHINA 2024 Thrives with Enhanced Original Chinese Design and…
Register to get free ticket for Furniture China 2024 and Maison Shanghai 2024 before 1st September. Register to get free ticket forFurnitureChina2024andMaison Shanghai 2024before 1 stSeptember. More Clearer Positioning with Increasing Exhibitor Lineup FurnitureChina2024at SNIEC will exceed past editions, to further promote furniture manufacturing productivity and global trade. Exhibitors from 26 countries will participate, expecting record numbers. Five...
PR Newswire
11/07/2024
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement…
Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potentialFS001 targets a novel tumor associated antigen, highly expressed across a range of solid tumors, identified through the application of Foreseen's proprietary proteomic platformsFS001 has demonstrated robust preclinical efficacy in multiple tumor models and exhibits a favorable preclinical safety profile ...
Nasdaq GlobeNewswire
11/07/2024
Leqembi approved for the treatment of Alzheimer's disease in Hong Kong
Leqembi selectively binds to soluble amyloid-beta (Aβ) aggregates (protofibrils[4]), as well as insoluble Aβ aggregates (fibrils) which are a major component of Aβ plaques in AD, thereby reducing both Aβ protofibrils and Aβ plaques in the brain. Leqembi is the first approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline through this mechanism. Leqembi selectively binds to soluble amyloid-beta (Aβ) aggregates (protofibrils [4] ), as well...
PR Newswire
11/07/2024
Novo Nordisk receives Complete Response Letter in the US for once-weekly basal…
Bagsværd, Denmark, 10 July 2024– Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) covering the Biologics License Application for once-weekly basal insulin icodec for the treatment of diabetes mellitus. In the letter, the FDA has requests related to the manufacturing process and the type 1 diabetes indication before the review of the application can be completed. Novo Nordisk is evaluating the content of the CRL and...
Nasdaq GlobeNewswire
10/07/2024
Coagulation Factor Deficiency Market - US to Have the Lion's Share Among the…
Key Takeaways from the Coagulation Factor Deficiency Market Report Key Takeaways from the Coagulation Factor Deficiency Market Report Discover which therapies are expected to grab the major coagulation factor deficiency market share @ Coagulation Factor Deficiency Market Report Coagulation Factor Deficiency Overview Coagulation factor deficiency diseases, also referred to as bleeding or clotting disorders, encompass a range of inherited or acquired conditions marked by the...
PR Newswire
10/07/2024
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
PRESS RELEASE REGULATED INFORMATION 10 July 2024, 06:00 p.m. CESTSEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNTAND NEW NUMBER OF SHARESGhent, Belgium, 10 July 2024 – Sequana Medical NV(Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that in the context of the confirmation of the contribution in kind of the receivables outstanding under the...
Nasdaq GlobeNewswire
10/07/2024
LBB Specialties Announces Principal Partnership with Sudarshan
Sudarshan's pigment line, including the Prestige, Sumicos, Sumicair and Sudacos ranges, leverages advanced manufacturing processes and rigorous quality controls to produce pigments with exceptional color fidelity, stability and safety. This innovative range includes products that cater to the latest trends in color cosmetics, offering formulators versatile options for creating stunning and long-lasting makeup products. Sudarshan's pigment line, including the Prestige,Sumicos, Sumicair and...
PR Newswire
10/07/2024
Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of…
"What Eligo has achieved shows that it's now possible to make specific changes to the DNA of bacteria in the gut, similar to how scientists have been editing human genes to investigate or treat genetic disorders," said David Bikard, cofounder of Eligo Bioscience and researcher at the Institut Pasteur in Paris. "What Eligo has achieved shows that it's now possible to make specific changes to the DNA of bacteria in the gut, similar to how scientists have been editing human genes to…
PR Newswire
10/07/2024
Medical Billing Market Evolution: From USD 16.8 Billion to USD 27.7 Billion |…
Browse in-depth TOC on "Medical Billing Market" Browse in-depth TOC on "Medical Billing Market" 360 - Tables48 - Figures300 - Pages Deployment Landscape The medical billing market is categorized into three deployment segments: cloud-based, on-premise, and SaaS-based solutions. As of 2023, the on-premise segment holds the largest market share. This preference is driven by healthcare institutions' stringent data security requirements and the need for customization...
PR Newswire
10/07/2024
PAP Devices Market to Be Worth $6.97 Billion by 2031- Exclusive Report by…
Positive airway pressure (PAP) devices pump air under pressure into the airway of the lungs. These devices prevent airways from collapsing, which may slow down breathing in people with respiratory problems such as obstructive sleep apnea. (OSA). Positive airway pressure (PAP) devices are used in hospitals, sleep clinics, and home healthcare settings to treat adult and pediatric or neonatal patients. Types of PAP devices include continuous positive airway pressure (CPAP) devices, bilevel positive…
PR Newswire
10/07/2024
Medical Spa Market Size to Hit USD 82.5 billion by 2034, at a 14.9% CAGR |…
The medical spa market is experiencing significant growth driven by a rising preference for medical aesthetics and a broader acceptance of cosmetic medical procedures. Medical spas operate under the supervision of licensed healthcare professionals, such as medical doctors, ensuring a higher standard of safety and efficacy compared to traditional spa settings. These establishments offer a unique blend of advanced aesthetic procedures and therapeutic services, combining the relaxing environment of…
PR Newswire
10/07/2024
Medical Case Management Market is projected to expand to USD 12.3 billion at a…
With the growing geriatric population across the world, the necessity to deliver better healthcare practices spurs. Geriatric healthcare management can consist of a wide range of medical assistance services. The growing preference for home care models is augmenting the size of the said ecosystem. Finance facilities, including banking services, medical assistance, and other legal activities can be facilitated using medical case management services. With the growing geriatric population across...
PR Newswire
10/07/2024
Recombinant Coagulation Factors Market to Be Worth $26.29 Billion by 2031 -…
Recombinant coagulation factors are glycoproteins produced by recombinant DNA technology. They are mainly used for the treatment of various coagulation disorders. They are gaining popularity due to their benefits, such as reduced risk of bloodborne disease transmission and effective treatment. Recombinant coagulation factors are glycoproteins produced by recombinant DNA technology. They are mainly used for the treatment of various coagulation disorders. They are gaining popularity due to…
PR Newswire
10/07/2024
FSH-free versus FSH-primed infertility treatment of women with polycystic ovary…
The number of matured oocytes after CAPA-IVM did not differ significantly between the non-FSH and FSH groups (13 [9; 18] vs. 14 [7; 18]; absolute difference –1 [95% confidence interval –5, 4]). There were also no significant between-group differences in other oocyte and embryology outcomes, including the number of cumulus-oocyte complexes, number of fertilized oocytes, total number of blastocysts and good blastocysts, and total number of frozen embryos. The live birth rate was 38.3% in the...
Nasdaq GlobeNewswire
10/07/2024
iHerb® Unveils New Global, Online Distribution Partnership with The Vitamin…
From supplements to skincare to grocery items, iHerb ships over 50,000 products from over 1,800 brands to more than 180 countries. With this partnership, health and wellness consumers can now access The Vitamin Shoppe's innovative range of premium brands, including The Vitamin Shoppe®, Vthrive The Vitamin Shoppe®, BodyTech®, and BodyTech® Elite, on iHerb's global, online platform. From supplements to skincare to grocery items, iHerb ships over 50,000 products from over 1,800 brands to more…
PR Newswire
10/07/2024
UPPAbaby Expands Innovation Footprint with 4moms Acquisition
"Acquiring 4moms marks a significant milestone for UPPAbaby as we continue our commitment to delivering exceptional products and experiences for parents," said Bob Monahan, CEO and Co-Founder of UPPAbaby. "4moms' expertise in innovation, design, and technology for in home products for growing families perfectly complements our 'Parenthood, Understood' brand mission. This acquisition will foster new opportunities for growth and collaboration, ensuring we remain at the forefront of…
PR Newswire
10/07/2024
XyloCor and SmartCella enter into license agreement for use of the Extroducer to…
XC001 is designed to reduce ischemic burden by creating new blood vessels in the heart through the local expression of multiple isoforms of vascular endothelial growth factor (VEGF). With the use of the Extroducer catheter, XyloCor can offer patients a better delivery option for local administration of XC001 directly to the heart, that is less invasive and eliminates potential risks associated with surgical administration. XC001 is designed to reduce ischemic burden by creating new blood...
PR Newswire
10/07/2024
Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of…
Skyhawk's SKY-0515 demonstrated dose-dependent huntingtin (HTT) mRNA reduction in healthy volunteers, with 72% reduction at the highest dose tested in the multiple ascending dose study SKY-0515 was generally well tolerated at all doses testedGiven these positive topline results, we anticipate dosing in the patient arm of the study in Q3 2024 and initiation of a Phase 2 study early next yearBOSTON, July10, 2024(GLOBE NEWSWIRE) --Skyhawk Therapeutics, Inc.,a clinical-stage...
Nasdaq GlobeNewswire
10/07/2024
Altri Comunicati